US Stock MarketDetailed Quotes

CTXR Citius Pharmaceuticals

Watchlist

0.1335
-0.0003-0.22%

Close Nov 25 16:00 ET

0.1351
+0.0016+1.20%

Post 20:01 ET

25.79MMarket Cap-556P/E (TTM)

Citius Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Citius Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 7.061M	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 7.061M--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Citius Pharmaceuticals Earnings Reports

8-K: Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2024 Financial Results and Provides Business Update

Aug 12 17:27 ET

10-Q: Q3 2024 Earnings Report

Aug 12 16:56 ET

10-Q: Q2 2024 Earnings Report

May 14 16:43 ET

8-K: Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update

May 14 16:32 ET

Analyst Rating

Updated: Nov 22, 2024

Buy

Buy
66.67%
Hold
33.33%
Sell
0.00%

Price Target

No Data

Heat List

Overall